People

François Fontaine

François Fontaine

François Fontaine is published by SFPIM with these professional/governance affiliations: Investment Manager — Operating team. Operating team employment is distinguished from governance and committee oversight. No personal investment is inferred. Neuvasq affiliation: François Fontaine has served as the General Advisor to the Société Fédérale de Participations et d’Investissements (SFPI) since December 2009. His responsibilities include overseeing investment projects in various sectors, such as new technologies, biomedical, real estate, waste treatment, and water and energy. Prior to his current role, François worked as an advisor for the tax unit of the Walloon Region where he was responsible for implementing and transferring regional taxes. He holds a Bachelor’s degree in law and tax sciences. François Fontaine is publicly named in the current Belgian official registry as a statutory permanent representative on the Newton Biocapital fund board. This is a specifically qualified fund-governance affiliation rather than an operating investment-team employee or a personal cash check. Newton Biocapital publicly documents this person as Statutory Permanent Representative — Fund I; Statutory Permanent Representative — Fund II. The affiliation is scoped to the published role, with no personal cash investment inferred. Bioxodes affiliation: François Fontaine holds a law degree from the University of Brussels and he is a specialist in Tax affairs. He was counsel in various public institutions and cabinet. He is currently general counsel to the Federal Holding and Investment Company (SFPI)-FPIM. SFPI is focusing its investments on innovative Belgian Companies, hoping to contribute to their financial and societal success story. Mr. Fontaine is also a Board member of several companies including biotechs.

Roles

SFPIM

Investment Manager

Current
Current
Newton Biocapital

Statutory Permanent Representative — Fund I

Current
Newton Biocapital

Statutory Permanent Representative — Fund II

Current
Bioxodes

Non-Executive Director

Current